Lilly investigating allegations of $4.9M in Chinese bribes

Carly Helfand Eli Lilly, the most recent company targeted with bribery accusations in China, is looking into the matter itself. The company says it is "deeply concerned" by ...

Breathe Deeply: A Lilly Lung Cancer Drug Offers A Pleasant Surprise

esilverman In a surprise development, Eli Lilly reported that a drug being developed to treat metastatic squamous non-small cell lung cancer, or NSCLC, increased overall survival ...

Lilly: Lung Cancer Drug Meets Phase III Endpoint

barbara.lempert Lilly Announces Phase III Necitumumab Study Meets Primary Endpoint of Overall Survival Study found improved overall survival in patients with stage IV squamous ...

Lilly Announces Deal to Train Minority Clinical Trial Investigators

mia.burns Lilly, Roswell Park Cancer Institute Partner to Train Minority Clinical Trial Investigators First-of-its-kind program aims to help improve diversity in clinical trials INDIANAPOLIS ...

Adocia and Lilly terminate collaboration

barbara.lempert Adocia reacquires exclusive development rights to ultra-fast acting insulin analog Lyon, France, July 29, 2013 – Adocia (NYSE Euronext Paris: FR0011184241 ...

Transition Therapeutics makes licensing pact for Lilly arthritis drug

Emily Mullin Toronto-based Transition Therapeutics today announced that it has acquired exclusive licensing of worldwide rights for Eli Lilly's experimental drug TT-601 for arthritis ...

Lilly earnings powered by price hikes and layoffs

Carly Helfand Eli Lilly's second-quarter earnings are up, but the company hasn't done it through rolling out new products or expanding its market. Bracing for the patent loss ...

Lilly To Freeze Pay Raises For Most Employees

esilverman Two months after disclosing plans to lay off more than 1,600 sales reps, Eli Lilly is now planning to suspend base pay raises for most employees next year and reduce employee ...

Lilly freezes salaries ahead of patent loss for Cymbalta

Eric Palmer Eli Lilly's CEO John Lechleiter was out for a couple of months as he dealt with some heart issues. He recently returned and guess what he brought with him? More bad ...

Lilly Plans A Bigger Study – And Bet – For Its Alzheimer’s Drug

esilverman Seven months after promising to start another Phase III trial of its solanezumab compound for Alzheimer’s in patients with a mild form of the disease, Eli ...

Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents

barbara.lempert Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents Continued insufficient Medicare coverage would be a significant setback for ...

Medicare won’t pay for Eli Lilly Alzheimer’s agent

Tracy Staton Medicare has put up a big roadblock to Eli Lilly's Alzheimer's screening product Amyvid. The Centers for Medicare & Medicaid Services says it will only pay ...
Page 4 of 6« First...23456
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS